Cargando…
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt
OBJECTIVES: The aim of the present work was to explore the perspectives of Egyptian Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine. METHODS: The survey is composed of 25 questions. Some questions were adapted from the global rheumatology alliance COVID-19 survey...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269986/ https://www.ncbi.nlm.nih.gov/pubmed/34244818 http://dx.doi.org/10.1007/s00296-021-04941-0 |
_version_ | 1783720703941410816 |
---|---|
author | Hammam, Nevin Tharwat, Samar Shereef, Rawhya R. El Elsaman, Ahmed M. Khalil, Noha M. Fathi, Hanan M. Salem, Mohamed N. El-Saadany, Hanan M. Samy, Nermeen El-Bahnasawy, Amany S. Abdel-Fattah, Yousra H. Amer, Marwa A. ElShebini, Emad El-Shanawany, Amira T. El-Hammady, Dina H. Noor, Rasha Abdel ElKhalifa, Marwa Ismail, Faten Fawzy, Rasha M. El-Najjar, Amany R. Selim, Zahraa I. Abaza, Nouran M. Radwan, Ahmed R. Elazeem, Mervat IAbd Mohsen, Wael Abdel Moshrif, Abdel Hafeez Mohamed, Eman F. Aglan, Loay I. Senara, Soha Ibrahim, Maha E. Khalifa, Iman Owaidy, Rasha El Fakharany, Noha El. Mohammed, Reem Hamdy A. Gheita, Tamer A. |
author_facet | Hammam, Nevin Tharwat, Samar Shereef, Rawhya R. El Elsaman, Ahmed M. Khalil, Noha M. Fathi, Hanan M. Salem, Mohamed N. El-Saadany, Hanan M. Samy, Nermeen El-Bahnasawy, Amany S. Abdel-Fattah, Yousra H. Amer, Marwa A. ElShebini, Emad El-Shanawany, Amira T. El-Hammady, Dina H. Noor, Rasha Abdel ElKhalifa, Marwa Ismail, Faten Fawzy, Rasha M. El-Najjar, Amany R. Selim, Zahraa I. Abaza, Nouran M. Radwan, Ahmed R. Elazeem, Mervat IAbd Mohsen, Wael Abdel Moshrif, Abdel Hafeez Mohamed, Eman F. Aglan, Loay I. Senara, Soha Ibrahim, Maha E. Khalifa, Iman Owaidy, Rasha El Fakharany, Noha El. Mohammed, Reem Hamdy A. Gheita, Tamer A. |
author_sort | Hammam, Nevin |
collection | PubMed |
description | OBJECTIVES: The aim of the present work was to explore the perspectives of Egyptian Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine. METHODS: The survey is composed of 25 questions. Some questions were adapted from the global rheumatology alliance COVID-19 survey for patients. RESULTS: 187 rheumatology staff members across Egypt from 18 universities and authorizations actively participated with a valid response. The mean time needed to complete the survey was 17.7 ± 13 min. Participants were 159 (85%) females (F:M 5.7:1). One-third agreed that they will be vaccinated once available, 24.6% have already received at least one dose, 29.4% are unsure while 16% will not take it. Furthermore, 70.1% agreed that they will recommend it to the rheumatic diseases (RD) patients once available, 24.1% are not sure while 5.9% will not recommend it. RD priority to be vaccinated against COVID-19 in descending order include SLE (82.9%), RA (55.1%), vasculitis (51.3%), systemic sclerosis (39.6%), MCTD (31.6%), Behcet's disease (28.3%). The most common drugs to be avoided before vaccination included biologics (71.7%), DMARDs (44.4%), biosimilars (26.7%), IVIg (17.1%) and NSAIDs (9.1%). CONCLUSIONS: The results of the study and specifically the low rate of acceptability are alarming to Egyptian health authorities and should stir further interventions to reduce the levels of vaccine hesitancy. As rheumatic disease patients in Egypt were not systematically provided with the vaccine till present, making the vaccine available could as well enhance vaccine acceptance. Further studies to investigate any possible side effects, on a large scale of RD patients are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00296-021-04941-0. |
format | Online Article Text |
id | pubmed-8269986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82699862021-07-09 Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt Hammam, Nevin Tharwat, Samar Shereef, Rawhya R. El Elsaman, Ahmed M. Khalil, Noha M. Fathi, Hanan M. Salem, Mohamed N. El-Saadany, Hanan M. Samy, Nermeen El-Bahnasawy, Amany S. Abdel-Fattah, Yousra H. Amer, Marwa A. ElShebini, Emad El-Shanawany, Amira T. El-Hammady, Dina H. Noor, Rasha Abdel ElKhalifa, Marwa Ismail, Faten Fawzy, Rasha M. El-Najjar, Amany R. Selim, Zahraa I. Abaza, Nouran M. Radwan, Ahmed R. Elazeem, Mervat IAbd Mohsen, Wael Abdel Moshrif, Abdel Hafeez Mohamed, Eman F. Aglan, Loay I. Senara, Soha Ibrahim, Maha E. Khalifa, Iman Owaidy, Rasha El Fakharany, Noha El. Mohammed, Reem Hamdy A. Gheita, Tamer A. Rheumatol Int Observational Research OBJECTIVES: The aim of the present work was to explore the perspectives of Egyptian Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine. METHODS: The survey is composed of 25 questions. Some questions were adapted from the global rheumatology alliance COVID-19 survey for patients. RESULTS: 187 rheumatology staff members across Egypt from 18 universities and authorizations actively participated with a valid response. The mean time needed to complete the survey was 17.7 ± 13 min. Participants were 159 (85%) females (F:M 5.7:1). One-third agreed that they will be vaccinated once available, 24.6% have already received at least one dose, 29.4% are unsure while 16% will not take it. Furthermore, 70.1% agreed that they will recommend it to the rheumatic diseases (RD) patients once available, 24.1% are not sure while 5.9% will not recommend it. RD priority to be vaccinated against COVID-19 in descending order include SLE (82.9%), RA (55.1%), vasculitis (51.3%), systemic sclerosis (39.6%), MCTD (31.6%), Behcet's disease (28.3%). The most common drugs to be avoided before vaccination included biologics (71.7%), DMARDs (44.4%), biosimilars (26.7%), IVIg (17.1%) and NSAIDs (9.1%). CONCLUSIONS: The results of the study and specifically the low rate of acceptability are alarming to Egyptian health authorities and should stir further interventions to reduce the levels of vaccine hesitancy. As rheumatic disease patients in Egypt were not systematically provided with the vaccine till present, making the vaccine available could as well enhance vaccine acceptance. Further studies to investigate any possible side effects, on a large scale of RD patients are warranted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00296-021-04941-0. Springer Berlin Heidelberg 2021-07-09 2021 /pmc/articles/PMC8269986/ /pubmed/34244818 http://dx.doi.org/10.1007/s00296-021-04941-0 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Observational Research Hammam, Nevin Tharwat, Samar Shereef, Rawhya R. El Elsaman, Ahmed M. Khalil, Noha M. Fathi, Hanan M. Salem, Mohamed N. El-Saadany, Hanan M. Samy, Nermeen El-Bahnasawy, Amany S. Abdel-Fattah, Yousra H. Amer, Marwa A. ElShebini, Emad El-Shanawany, Amira T. El-Hammady, Dina H. Noor, Rasha Abdel ElKhalifa, Marwa Ismail, Faten Fawzy, Rasha M. El-Najjar, Amany R. Selim, Zahraa I. Abaza, Nouran M. Radwan, Ahmed R. Elazeem, Mervat IAbd Mohsen, Wael Abdel Moshrif, Abdel Hafeez Mohamed, Eman F. Aglan, Loay I. Senara, Soha Ibrahim, Maha E. Khalifa, Iman Owaidy, Rasha El Fakharany, Noha El. Mohammed, Reem Hamdy A. Gheita, Tamer A. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title | Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title_full | Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title_fullStr | Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title_full_unstemmed | Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title_short | Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt |
title_sort | rheumatology university faculty opinion on coronavirus disease-19 (covid-19) vaccines: the vaxurvey study from egypt |
topic | Observational Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269986/ https://www.ncbi.nlm.nih.gov/pubmed/34244818 http://dx.doi.org/10.1007/s00296-021-04941-0 |
work_keys_str_mv | AT hammamnevin rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT tharwatsamar rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT shereefrawhyarel rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elsamanahmedm rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT khalilnoham rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT fathihananm rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT salemmohamedn rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elsaadanyhananm rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT samynermeen rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elbahnasawyamanys rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT abdelfattahyousrah rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT amermarwaa rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elshebiniemad rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elshanawanyamirat rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elhammadydinah rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT noorrashaabdel rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elkhalifamarwa rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT ismailfaten rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT fawzyrasham rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elnajjaramanyr rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT selimzahraai rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT abazanouranm rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT radwanahmedr rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT elazeemmervatiabd rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT mohsenwaelabdel rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT moshrifabdelhafeez rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT mohamedemanf rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT aglanloayi rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT senarasoha rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT ibrahimmahae rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT khalifaiman rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT owaidyrashael rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT fakharanynohael rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT mohammedreemhamdya rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT gheitatamera rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt AT rheumatologyuniversityfacultyopiniononcoronavirusdisease19covid19vaccinesthevaxurveystudyfromegypt |